Literature DB >> 15478806

Variations in the sequence and expression of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) and their relationship to chloroquine resistance in vitro.

Valérie Durrand1, Antoine Berry, Rithy Sem, Philippe Glaziou, Joelle Beaudou, Thierry Fandeur.   

Abstract

Chloroquine has been widely used for malaria treatment and prophylaxis for several decades, but its usefulness has now declined with the emergence of chloroquine resistance. Recent studies showed that the K76T mutation in the PfCRT protein, initially associated to chloroquine-resistant parasites, is sometimes also present in susceptible parasites, suggesting that other factors control the expression of the resistance phenotype. Here, we sought new mutations in the Pfcrt gene and used real-time PCR to investigate variations in the expression level of this gene with respect to the in vitro response to chloroquine. About 40 Cambodian isolates of Plasmodium falciparum were selected on the basis of their response to chloroquine in vitro. The Pfcrt gene was characterised by amplifying and sequencing the full-length cDNA. Twelve point mutations--M74I, N75D/E, K76T, A144F, L148I, I194T, A220S, Q271E, N326S, T333S, I356T and R371I--were detected. Mutations identified at positions 144, 148, 194 and 333 had never been described before. These mutations define six distinct haplotypes, distributed heterogeneously throughout Cambodia. Only the mutations at positions 74-76, 220 and 271 were significantly associated with the in vitro response to chloroquine. Three major haplotypes--MNK/A/Q, IDT/S/E and IET/S/E--accounted for all the isolates examined. The MNK/A/Q haplotype corresponded to susceptible isolates whereas parasites with the IDT/S/E haplotype displayed an intermediate response to chloroquine and those with the IET/S/E haplotype displayed the highest IC50 values. Phylogenic analysis suggested that the IDT and IET haplotypes (positions 74-76) arose independently from the wild-type MNK sequence. We found that the expression level of Pfcrt, evaluated by real-time PCR, had no effect on the response of the parasite to the drug in vitro. Similarly, in a CQ-resistant strain short-term cultured in the presence of CQ, no change was observed in the level of transcripts. These results are discussed in light of recent finding suggesting the possible involvement of other transporters in CQ-resistance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15478806     DOI: 10.1016/j.molbiopara.2004.03.016

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  47 in total

1.  Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana.

Authors:  Eric Legrand; Joséphine Yrinesi; Marie-Thérèse Ekala; Julie Péneau; Béatrice Volney; Franck Berger; Christiane Bouchier; Stéphane Bertani; Lise Musset; Jean-Baptiste Meynard; Odile Mercereau-Puijalon
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

Review 2.  Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.

Authors:  Robert L Summers; Megan N Nash; Rowena E Martin
Journal:  Cell Mol Life Sci       Date:  2012-06       Impact factor: 9.261

3.  Origin and dissemination of chloroquine-resistant Plasmodium falciparum with mutant pfcrt alleles in the Philippines.

Authors:  Nanhua Chen; Danny W Wilson; Cielo Pasay; David Bell; Laura B Martin; Dennis Kyle; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

4.  The patterns of mutation and amplification of Plasmodium falciparum pfcrt and pfmdr1 genes in Thailand during the year 1988 to 2003.

Authors:  Mathirut Mungthin; Nantana Suwandittakul; Wanna Chaijaroenkul; Kanchana Rungsrihirunrat; Pongchai Harnyuttanakorn; Aree Seugorn; Kesara Na Bangchang
Journal:  Parasitol Res       Date:  2010-05-07       Impact factor: 2.289

5.  Multiple Novel Mutations in Plasmodium falciparum Chloroquine Resistance Transporter Gene during Implementation of Artemisinin Combination Therapy in Thailand.

Authors:  Pattakorn Buppan; Sunee Seethamchai; Napaporn Kuamsab; Pongchai Harnyuttanakorn; Chaturong Putaporntip; Somchai Jongwutiwes
Journal:  Am J Trop Med Hyg       Date:  2018-10       Impact factor: 2.345

Review 6.  Drug-resistant malaria - an insight.

Authors:  John E Hyde
Journal:  FEBS J       Date:  2007-09       Impact factor: 5.542

7.  In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005.

Authors:  Eric Legrand; Béatrice Volney; Jean-Baptiste Meynard; Odile Mercereau-Puijalon; Philippe Esterre
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

8.  Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum.

Authors:  Stephanie G Valderramos; Juan-Carlos Valderramos; Lise Musset; Lisa A Purcell; Odile Mercereau-Puijalon; Eric Legrand; David A Fidock
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

9.  Longitudinal survey of Plasmodium falciparum infection in Vietnam: characteristics of antimalarial resistance and their associated factors.

Authors:  Rie Isozumi; Haruki Uemura; Duc Dao Le; Van Hanh Truong; Duc Giang Nguyen; Viet Vien Ha; Quang Phuc Bui; Van Tuan Nguyen; Shusuke Nakazawa
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

10.  Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.

Authors:  Pharath Lim; Alisa P Alker; Nimol Khim; Naman K Shah; Sandra Incardona; Socheat Doung; Poravuth Yi; Denis Mey Bouth; Christiane Bouchier; Odile Mercereau Puijalon; Steven R Meshnick; Chansuda Wongsrichanalai; Thierry Fandeur; Jacques Le Bras; Pascal Ringwald; Frédéric Ariey
Journal:  Malar J       Date:  2009-01-12       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.